News

Hemotune launches feasibility project with AstraZeneca

We congratulate our portfolio company hemotune on the initiation of a joint feasibility project with the renowned pharmaceutical company AstraZeneca.

The project is based on hemotune’s HemoSystem, a therapeutic blood purification platform under development, designed for the selective and efficient removal of large biomolecules directly from blood. Unlike conventional blood filters, this process is based on proprietary nanostructured magnetic particles.

More information in the press release under the following Link.

More about hemotune

Thermosome receives BfArM approval Overview Follow-on investment in Lunaphore
Want to learn more about OCCIDENT?

News

About

New OCCIDENT Website

Having sharpened our investor profile and revised our communi­cation, we get to the point: OCCIDENT – The Science Investor.